Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS (PlinytheElder)

Clinical Trial ID NCT04739384

Rank	Title	Journal	Year	PubWeight™‹?›
1	Prasugrel versus clopidogrel in patients with acute coronary syndromes.	N Engl J Med	2007	17.85
2	Long-term use of ticagrelor in patients with prior myocardial infarction.	N Engl J Med	2015	8.69
3	Demographic and epidemiologic drivers of global cardiovascular mortality.	N Engl J Med	2015	1.70
4	Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial.	J Am Coll Cardiol	2016	1.41
5	Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.	Eur Heart J	2015	0.90
6	Antithrombotic therapy in the elderly.	J Am Coll Cardiol	2010	0.83
7	2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).	Eur Heart J	2017	0.75